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論文内容の要 旨
 Summary 
  Most chemical mutagens bind covalently, or intercalate, to DNA to form adduct 
or complexes leading to a variety of lesions that are processed by cellular error-
free repair mechanisms. However, some of these adducts escape from the repair 
processes, and are converted into mutations. A general strategy for studying 
mutagenic mechanisms is to determine the forward mutation spectrum, obtained 
after random modification with a mutagen, of a gene in which mutations confer a 
readily identifiable phenotype. 
  For decades, the somatic mutation theory has been the prevailing paradigm in 
cancer research. Its premises are that cancer is derived from a single somatic cell 
that has accumulated multiple DNA mutations, and that cancer is a disease of cell 
proliferation caused by mutations in genes that control proliferation and the cell 
cycle. This theory supported that two distinct classes of genes, proto-oncogenes 
and tumor-suppressor genes are involved in the cancer process. Carcinogens 
directly alter the DNA sequence of cancer-related genes, mutations in multiple 
oncogenes may be activated in a cell, while multiple tumor-suppressor genes may 
be inactivated. The findings of multiple genetic changes (including point 
mutations, chromosomal translocations, deletions, gene amplification, and 
numerical chromosome changes) in activated proto-oncogenes and inactivated
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tumor-suppressor genes provide experimental support for Boveri's somatic 
mutation theory of carcinogenesis. 
  More recently, an alternative theory has gained currency. It's focus on the role 
of  aneuploidy-large-scale aberrations in the chromosomes. Because of a random 
accident or damage by carcinogens to chromosomes or mitotic machinery, a 
dividing cell distributes its chromosomes unevenly between two daughter cells, 
leaving both aneuploid. Most of these resulting cells are not viable and die, but a 
surviving cell may continue proliferating. Low aneuploidy in its offspring begins 
to compromise their internal functioning, but they are not yet multiplying 
excessively. Skewed dosages of proteins generated by the cells' irregular 
chromosome complements cause instability that further disrupts regulatory and 
DNA-maintenance processes. Additional chromosome breakage, structural 
rearrangements and duplication errors arise and cells begin exhibiting 
progressively more deviant traits as aneuploidy increases and their protein 
production grows more aberrant. These changes include atypical appearance and 
hyperproliferation, leading to formation of a tumor. 
  Identification of the genes involved in carcinogenesis and elucidation of the 
mechanisms of their activation or inactivation allows a better understanding of 
how chemical mutagens and/or carcinogens influence the process of neoplastic 
evolution. One of the best methods for initial characterization of genes involved in 
DNA damage and repair is to analyze the spectrum of mutations created in their 
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absence. Similarly, the mutagenic effects of external agents can be measured by 
analyzing their mutation spectra. 
  Numerous genetic toxicity tests have been proposed for identifying mutagens. 
Among them, the Salmonella mutation (Ames test) has been the most widely used. 
Although, the Salmonella test assay is very sensitive for detecting mutations, 
such test can not detect an important key step in the carcinogenesis process: 
Aneuploidy. In our laboratory, we tried to set up a genotoxicity test to identify 
mutagenic chemicals based on their effects on two new constructed 
Saccharomyces cerevisiae strains. The understanding and the establishment of the 
mechanisms involved in mutagenic activity will enable us to a better prediction 
of carcinogenicity. Yeast mutations offer a window into human diseases which has 
been even further facilitated by the availability of the complete genome sequence 
of S. cerevisiae, published in 1996  . 
  A key objective of this study is to evaluate the genetic toxicity of  1- 
nitropyrene and proflavine through their abilities to induce mutations on the 
 CANI gene of two yeast strains. The establishment of the mechanisms involved in 
the induced mutations will enable us to a better prediction of chemicals' 
carcinogenic potential. Thus, we have attempted to characterize the genetic 
alterations that inactivate the endogenous  CANI gene either in haploid cells or in 
heterozygous diploid cells.
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  We started by the evaluation of the mutagenicity of 1-NP, so we found, first, 
that  1-NP, the predominant nitropolycyclic hydrocarbon in diesel exhaust known 
for their ability to induce oxidative stress resulting in lipid peroxidation, has a 
substantial toxic effect on S. cerevisiae probably associated to reactive oxygen 
species (ROS) production which is often found to be a common part of the 
cytotoxic response due to the possible roles for ROS in the initiation of DNA 
damage. Also, it has been reported that 1-NP induced apoptosis in  Hepalcic7 cells. 
The authors suggested that after exposure to the chemical cells may survive with 
DNA damage, thereby increasing its mutagenic potential. 
  Further, we observed that without metabolic activation 1-NP increased the 
frequency of mutations in the endogenous  CAN1 gene in haploid and diploid yeast 
cells. Also, we found that  1-NP, in the diploid cells, caused a 9.5-fold increase in 
recombination, including gene conversion and crossover, with regard to the 
untreated control.  On the other hand, 1-NP did induce chromosome loss at lower 
frequency over the spontaneous level. Thus,  1-NP can induce point mutations and 
recombination in yeast. There is some controversy regarding the genotoxic effects 
of 1-NP towards yeast. While some authors reported recombinogenicity, others 
indicated an absence of recombinogenic effects of  1-NP in yeast. It was argued 
that a lack of functional nitroreductase activity in yeast was the reason for the 
absence of recombinogenic  activity.  1-NP could be activated through 
nitroreductase or liver microsome-mediated oxidation. Indeed in S. typhimurium, 
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a strain deficient in the nitroreductase (e.g., TA98NR) is not very responsive to 
the mutagenic action of  1-NP compared to the nitroreductase-proficient parental 
strain TA98. Thus, nitroreductase is important to activate 1-NP in the absence of 
microsomal activation and no homologous sequences of S. typhimurium 
nitroreductase was found in yeast. 
  In this study, we observed the induction of mutations and recombination in yeast 
even without activation, consistent with previous results suggesting that 
nitropyrenes in yeast are not direct-acting mutagens, but are metabolized by the 
cells to give rise to a mutagenic product. Recently, although yeast does not have 
sequence homologous to Salmonella nitroreductase, in  silica analysis identified a 
new group of nitroreductases-like proteins in yeast. Thus, these nitroreductases 
may be enzymes that metabolize 1-NP to active forms which cause mutations as 
well as recombination. The elucidation of metabolic processes involved in the 
activation of nitropyrenes in yeast is an important issue. We observed increases in 
base substitutions and frameshifts, the frequencies of these events being 9.19 x  10-
6 and 6.36 x  10-6, respectively. Among the 14 frameshifts sites detected, 6 occurred 
at G:C sites and 8 at A:T sites, 7 at run sites and 7 at non-run sites, and  11 at plus 
frameshift sites and 3 at minus frameshift sites. Literature data reported that 
mutations occurred more frequently at G:C sites than A:T sites as evidence of the 
formation of the of the most frequent DNA adduct dG-C8-AP. This difference 
between the 1-NP induced mutations in yeast and the other microorganisms could 
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be explain by the difference in metabolic activation of the chemical, which mean 
that the yeast strain used in this study is capable of activating 1-NP via unknown 
process in addition to the one involving nitroreductase-like enzymes. 
  Among the base substitutions observed,  G:C4A:T transitions predominated. 
Also, for diploid YAS3001 cells exposed to 1-NP, an increase in gene conversion 
event was found which is known to be the main mechanism associated with  1-NP-
induced loss of heterozygosity. We observed an increase in the rate of both gene 
conversion and crossover after treatment concluding that 1-NP can induce not 
only point mutations in yeast, bacteria and mammalian cells, but also induce 
recombination in yeast and mammalian cells. The gene conversion and crossover 
inducing activity of 1-NP was 10 to 30-fold, respectively, greater than its point 
mutation-inducing activity. Concerning chromosome loss,  1-NP induced only 2 
such events among 1250 CanR mutants. This result is of significant importance if 
we compare it with the total absence of any chromosome loss (zero events) among 
the spontaneous mutation. Thus, in our experimental conditions, 1-NP has an 
aneugenic effect in yeast. It may thus be concluded that a mutagen that increases 
the rate of recombination will contribute to the expression of heterozygous 
mutations and thereby catalyze an important step of carcinogenesis. As reported 
in the literature, 1-NP is catalogued as a carcinogen and our results obtained with 
yeast indicate that 1-NP is highly prone to induce recombination and chromosome 
loss which can be considered as enough and efficient to predict cancer. 
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  For the mutagenicity assessment of the acridine family member, proflavine. We 
found that this fused linear tricyclic molecule, has a significant toxic effect on S. 
cerevisiae confirming the previous results reported that proflavine produced cell 
killing following incubation with yeast cells but after a subsequent irradiation with 
visible light. Evidence has been presented by the author that respiration-deficient 
mutants "petites" in yeast can be induced by proflavine and analogues through a 
photodynamic process. 
  We demonstrated that proflavine induced  Cans to CanR mutations both in  haploid 
and in diploid cells with a frequency of 10.6-fold and 15.3-fold higher than the 
spontaneous level, respectively, Previous literature data reported similar results 
when the effect of some acridines on the reversion from  trp- to  trp+ was examined 
for a growing haploid yeast strain of Saccharomyces cerevisiae. The acridines 
tested were characteristically non-mutagenic. Only proflavine showed significant 
reversion over spontaneous levels, with a 3-4-fold increase of revertants. 
Irradiation of the cells sensitized with proflavine brought about a marked increase 
(20-fold) in the reversion rate to  trp'  . 
  Recent review reported, concluded that by intercalation the acridines act as 
frameshift mutagens in bacteriophage and bacterial assays, and especially in 
repetitive DNA sequences. We were able to generalize this conclusion to yeast. 
Thus, we observed that proflavine increased the frequency of frameshift mutations 
in the endogenous  CAN] gene in both haploid and diploid yeast cells. The 
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frequency induced by Proflavine was 28.5-fold higher than untreated control. 
Among the 20 plus (+) frameshifts identified, 13 at runs of identical bases and 7 at 
non-runs of bases, also, 7 occurred at G:C sites and 13 at A:T sites. Concerning 
base substitution mutations, it's worth noting that several works reported that 
proflavine causes a very low amounts of base substitution mutagenesis, at least in 
"in  vitro" systems. In our study, we observed that the proportion of base 
substitution mutation was not significantly different from that of the untreated 
control. Finally, we found that for the diploid strain, proflavine induced gene 
conversion about 6-fold more than point mutations in the  CAN1 gene. Also, we 
found that the frequencies of induced point mutation were almost the same in 
haploid and diploid cells, suggesting that the mechanisms involved in point 
mutations for both strain  are probably the same. Furthermore, under experiment 
conditions, we found that proflavine did not have any aneugenic effect on yeast 
because of the absence of chromosome loss events. Although proflavine do induce 
mutations in several microorganisms (bacteria, mammalian cells and yeast...) this 
chemical do not induce cancer in rodents and is categorized as non-carcinogens. 
Many explanations have been suggested to explain the existence of mutagenic non-
carcinogens. These include: metabolic differences between the in vivo 
carcinogenicity test and in vitro Salmonella and/or other mutation test conditions; 
the differences between the effective dose in vitro, and the in vivo distribution of 
the agent and its effective dose; the possibility that low levels of mutagenic
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contaminants, which may not reach a sufficient concentration to produce tumors, 
are responsible for the mutation test response; differences in DNA repair among 
species. 
  To these explanations we can add that, in our case, proflavine didn't show any 
aneugenic effect as for 1-nitropyrene, which mean that aneuploidy or loss of 
heterozygosity is a key step in the carcinogenesis process. Also it's very important 
to emphasis that the salmonella and other bacterial mutation tests can not detect 
aneuploidy event. This make our test using a diploid yeast strain the one of choice 
to study the mutagenicity of chemicals and the mechanisms involved as a first step 
to their carcinogenicity evaluation (prediction). Of course, we need to subject 
more chemicals (known mutagens, carcinogens and non-carcinogens) to this 
mutation test using our diploid yeast strain and try to gather data in order to 
confirm the accuracy of its carcinogenicity prediction.
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論文審査結果の要旨
発がんは,5・-10個のがん遺伝子及びがん抑制遺伝子の突然変異が蓄積す ることで生 じると考
えられている(多 段階発がんモデル)。このモデルは,多 くのがん細胞の遺伝子を調べると,塩基
置換型突然変異が確かにあること,多 くの突然変異誘発化学物質は発がん作用 もあることが背景
として出来上がったものである。一方,最 近の詳細な研究の結果,発 がん作用はあるが突然変異
誘発作用 のない化学物質が多数あることが明 らか となってきた(例 えば,防 かび剤のo-phenyl
pheno1等)。突然変異誘発作用はあるが,発 がん作用のない化学物質 も多数見つかっている(例 え
ば,ヒ ドロキシルアミンな ど)。突然変異誘発作用の無い発がん物質の場合,DNA損傷を作ること
なく,他方 ヒ ト培養細胞では染色体の変化 を導 くことが多い。発がん作用のない突然変異誘発物
質の場合,突 然変異を誘発す るが,染 色体への作用は大変弱い。突然変異誘発 も発がん作用も陽
性である多くの化学物質の場合,塩 基置換突然変異 を誘発すると共に染色体への作用も同様 に強
い。このよ うな現状を背景 として,RhenimiLallaRajaaは,変異誘発作用 と発がル性が陽陸の ヒ
ドロカーボンである1-nitorepyrene(1-NP)と,突然変異誘発性はあるが発がんの見 られないヘテ
ロサイクリンの一種proflavin(PF)について,そ の遺伝的作用 を,出芽酵母を用いて明 らかに し
た。一倍体酵母を用いた場合,1-NPもPFもDNAとはインターカレーションで相互作用することが知
られてお り,そ の特徴 としてフレームシフ ト型突然変異を共に高頻度で誘発 した。一方,2倍 体
酵母を用いた場合,1-NPもPFも遺伝子変換 と組み換えを高頻度で誘発 したほかに,1-NPでは染
色体の喪失(異 数性)も 一定の頻度で誘発 した。一方,PFの場合は,異 数性 の誘発 は見 られ な
い。がん細胞の場合,が ん関連遺伝子 に塩基置換型の突然変異が見られるほかに,異 数性 も同 じ
くらい高頻度で観察 される。1-NPはマウスに発がん作用を示 し異数性 も誘導する。PFは発がん作
用が無 くて,酵 母で異i数陸を誘導 しない。以上の結果を基に,RhenimiLallaRajaaは,多段階発
がんの課程には異数性形成が関わること,突然変異誘発作用のない発がん作用の根底には異数性
形成の有無があること,突然変異を誘発するが発がん作用のない化学物質には異数性誘発力がな
い可能 性があることなどを議論 した。以上の結果は,RhenimiLallaRajaaが自立して研究活動を
行 うに必要な高度の研究能力 と学識を有す ることを示 している。 したがって,本 論文は,博 士
(生命科学)の 博士論文 として合格 と認 める。
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